Clinical Trials
All Clinical Trials - Page 26 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04873050Phase 4Recruiting
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
Semaglutide
- NCT05027308Phase 3Completed
A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
Teduglutide
- NCT06118203N/ACompleted
Semaglutide Use in Acute Pulmonary Embolism
Semaglutide
- NCT04979130Phase 4Completed
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
Semaglutide
- NCT05184374N/AUnknown
Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH
Gonadorelin
- NCT06020456N/ACompleted
Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A
Desmopressin
- NCT05194124Phase 3Completed
Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway
Setmelanotide
- NCT04919226Phase 3Active Not Recruiting
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
Octreotide
- NCT05153772Phase 2Active Not Recruiting
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
Octreotide
- NCT04989946Phase 1/Phase 2Active Not Recruiting
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Gonadorelin
- NCT05857085Phase 4Completed
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
Semaglutide
- NCT04522622Phase 4Recruiting
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Teriparatide
- NCT05153564Phase 1Completed
A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
Semaglutide
- NCT05093634Phase 3Completed
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
Setmelanotide
- NCT05050084Phase 3Active Not Recruiting
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Gonadorelin
- NCT05153590N/ACompleted
A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland
Liraglutide
- NCT07028320Phase 3Completed
To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk
Teriparatide
- NCT05173714Phase 2Recruiting
Sit Less, Interact and Move More (SLIMM) 2 Study
Semaglutide
- NCT05151016EARLY_Phase 1Unknown
Long-term Use of Mifepristone in the Treatment of Adenomyosis
Gonadorelin
- NCT05013229Phase 3Completed
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
Semaglutide
- NCT05111912Phase 2Completed
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Liraglutide
- NCT04963231Phase 2Completed
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway
Setmelanotide
- NCT05144984Phase 2Completed
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
Semaglutide
- NCT05119179Phase 4Recruiting
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
Semaglutide
- NCT05057546Phase 4Active Not Recruiting
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
Gonadorelin
- NCT05132088Phase 3Completed
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
Semaglutide
- NCT05086445Phase 1Completed
A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
Orforglipron
- NCT04243629N/AUnknown
Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
Pramlintide
- NCT05110794Phase 1Completed
A Multiple-Dose Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05059236Phase 2Completed
A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.
Gonadorelin
- NCT05129891Phase 1Completed
A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
Semaglutide
- NCT05171751N/ACompleted
Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia
Octreotide
- NCT06182891N/ACompleted
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
Dulaglutide
- NCT04958109Phase 1Completed
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test
Kisspeptin
- NCT05050942Phase 3Active Not Recruiting
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Octreotide
- NCT05159752Phase 2Unknown
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Afamelanotide
- NCT05096598Phase 1Completed
A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
Petrelintide
- NCT04199728Phase 1/Phase 2Completed
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
Liraglutide
- NCT04455750Phase 3Active Not Recruiting
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
Gonadorelin
- NCT04931342Phase 2Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
Gonadorelin
- NCT05064735Phase 3Completed
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
Semaglutide
- NCT05034783EARLY_Phase 1Unknown
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Exenatide
- NCT05051579Phase 2Completed
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
Orforglipron
- NCT05048901Phase 1/Phase 2Recruiting
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
Lanreotide
- NCT05051566Phase 1Completed
A Multiple Dose Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05048719Phase 2Completed
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT05035095Phase 3Completed
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
Semaglutide
- NCT04897802Phase 4Completed
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Exenatide
- NCT04615871Phase 2Unknown
Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
Semaglutide
- NCT05056246Phase 1Completed
Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants
Maridebart-Cafraglutide